Codexis (CDXS) EBIT Margin (2010 - 2026)

Codexis (CDXS) recorded quarterly EBIT Margin of 52.75% in Q1 2026, down 294.4% quarter-over-quarter from 27.13% in Q4 2025, and up 21884.0% on a YoY basis from N/an in Q1 2025.

Codexis (CDXS) EBIT Margin (2010 - 2026) Analysis & Trends

Codexis' EBIT Margin history runs 17 years deep, the most recent figure standing at 52.75% for Q1 2026.

  • In Q1 2026, EBIT Margin rose 21884.0% year-over-year to 52.75%; the TTM figure through Mar 2026 stood at 37.51% (up 9722.0% YoY), while the FY2025 annual figure was 59.3%, up 3931.0% from the prior year.
  • EBIT Margin was 52.75% for Q1 2026 at Codexis, down from 27.13% in the prior quarter.
  • In the past five years, EBIT Margin ranged from a high of 27.13% in Q4 2025 to a low of 345.59% in Q3 2023.
  • Historically, EBIT Margin has averaged 118.96% across 5 years, with a median of 69.63% in 2024.
  • The sharpest annual moves came in 2023 and 2026: EBIT Margin sank 31473 bps in 2023, then soared 21884 bps in 2026.
  • A 5-year view of EBIT Margin shows it stood at 66.92% in 2022, then surged by 108 bps to 5.62% in 2023, then slumped by 709 bps to 34.21% in 2024, then soared by 179 bps to 27.13% in 2025, then sank by 294 bps to 52.75% in 2026.
  • The last three EBIT Margin figures came in at 52.75% (Q1 2026), 27.13% (Q4 2025), and 220.31% (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT Margin (Qtr)
1 Alterity Therapeutics 719,706.53 Bn 719,706.50 Bn - -
2 Belite Bio 55,800.00 Bn 55,800.00 Bn - -
3 Quantum Biopharma 18,182.30 Bn 18,182.29 Bn - -
4 Legend Biotech 3,154.00 Bn 3,153.71 Bn 242.10 Mn -6.43%
5 Akari Therapeutics 1,844.30 Bn 1,844.29 Bn - -
6 Evaxion A 1,567.96 Bn 1,567.94 Bn - -
7 Psyence Biomedical 251.43 Bn 251.42 Bn - -
8 Vertex Pharmaceuticals 112.56 Bn 105.31 Bn 2.59 Bn 38.10%
9 Abivax 94.37 Bn 94.37 Bn - -
10 Codexis 236.00 Mn 170.86 Mn 13.18 Mn -52.75%

Historic Data

Download Data
DateValue
Mar 31, 2026 -52.75%
Dec 31, 2025 27.13%
Sep 30, 2025 -220.31%
Jun 30, 2025 -83.91%
Mar 31, 2025 -271.59%
Dec 31, 2024 -34.21%
Sep 30, 2024 -129.02%
Jun 30, 2024 -284.90%
Mar 31, 2024 -69.63%
Dec 31, 2023 5.62%
Sep 30, 2023 -345.59%
Jun 30, 2023 -252.52%
Mar 31, 2023 -182.29%
Dec 31, 2022 -66.92%
Sep 30, 2022 -30.86%
Jun 30, 2022 -6.79%
Mar 31, 2022 -23.73%
Dec 31, 2021 -42.39%
Sep 30, 2021 3.62%
Jun 30, 2021 -17.62%